Personally for me, the quarterly all but confirmed our inclusion with both BBI and POC1 (i.e., it made it seem extremely unlikely that we would be dropped from either project now, assuming both projects make it to completion).
BBI: "Work on Phase 3 of the BBI project was commenced"
POC1: "A decision has been made to expand Mix&Go testing"
I don't know about anyone else, but that vote of confidence made me personally think this has been one of the better quarterlies for a while.
- Forums
- ASX - By Stock
- ADO
- Ann: Quarterly Activities Report Appendix 4C
Ann: Quarterly Activities Report Appendix 4C, page-11
-
- There are more pages in this discussion • 209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $972 | 46.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 567472 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 309108 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 567472 | 0.021 |
15 | 2329550 | 0.020 |
8 | 2890767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 309108 | 3 |
0.023 | 844552 | 6 |
0.024 | 306228 | 2 |
0.025 | 357001 | 5 |
0.027 | 573112 | 1 |
Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online